42
the causal agent of bovine TB, may be underestimated in humans [1] [2] [3] [4] . Incorrect extrapolation of data from high--43 income, low TB burden countries has likely resulted in the misconception that only a small number of humans
44
suffer from pulmonary and extra--pulmonary TB caused by M. bovis globally. This has resulted in a general lack of 45 awareness 2 among healthcare providers and public health officials regarding the importance of M. bovis as a 46 causal agent of human TB (hereafter referred as zoonotic TB). In this article, we highlight the global human and 47 veterinary public health challenges posed by zoonotic TB and outline short, medium, and long term actions to 48 improve its prevention, diagnosis, and treatment at the 'animal--human' interface. 
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bovis in people has been steadily increasing [10] [11] [12] . In San Diego California, M. bovis accounted for 45% of TB cases 84 in children and 6% of adult TB cases 10,11 . Importantly, one study in California found that mortality rates during 85 treatment were higher for M. bovis patients when compared to patients infected with M. tb 10 
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Given the subsistence nature and reliance on animals as a source of livelihood in low--income countries, it is 160 expected that the economic impact to the individual farmer will be important. 
